蛋白质氨酸甲基转移酶 (PRMT) 在神经退行性疾病中的功能影响
Efthalia Angelopoulou1,2, Efstratios-Stylianos Pyrgelis1, Chetana Ahire3
11st Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 11528 Athens, Greece.
Biology
|September 28, 2023
概括
蛋白质氨酸甲基转移酶 (PRMTs) 在神经退行性疾病 (如阿尔茨海默氏症和帕金森症) 中至关重要. 针对PRMT提供了一个有前途的新治疗策略,用于这些条件.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 遗传学 是一个遗传学.
背景情况:
- 全球人口老龄化正在增加神经退行性疾病的患病率.
- 常见的病理生理机制,包括遗传和环境因素,是这些疾病的基础.
- 蛋白质氨酸甲基转移酶 (PRMT) 调节关键的神经元功能,如生存,轴突运输和髓化.
研究的目的:
- 审查PRMT在神经退行性疾病病理生理学的作用.
- 阐明PRMTs对神经退行产生影响的机制.
- 突出PRMTs作为神经退行性疾病的潜在治疗点.
主要方法:
- 关于PRMT和神经退行性疾病现有研究的文献综述.
- 对PRMTs参与神经元健康相关的细胞机制的分析.
- 检查PRMT在特定神经退行性疾病中的作用.
主要成果:
- PRMTs与阿尔茨海默病,帕金森病,FTD-ALS,亨廷顿病,SMA和SBMA有关.
- PRMTs影响基因转录,RNA剪接和参与氧化应激,亡和神经炎症的信号通路.
- PRMTs的失调有助于蛋白质积累和神经传递缺陷.
结论:
- 在各种神经退行性疾病的发病过程中,PRMT发挥着重要作用.
- 了解PRMT的机制,可以了解疾病的发展.
- 针对PRMTs代表了神经退行性疾病的新疗法.
相关概念视频
Parkinson's Disease: Overview
590
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
590
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Role of Neurotransmitters in Memory
611
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
611
Alzheimer's Disease: Overview
513
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
513
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K


